LOGIN
AAOS2017: Similar Hb drop and transfusion rate between oral and IV TXA in THA
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
Patients undergoing primary total hip replacement were included in this randomized controlled trial to evaluate the comparative efficacy of oral and intravenous tranexamic acid (TXA) in reducing blood loss and limiting the need for blood transfusions. The number of patients included in this trial was not clearly reported in the conference abstract, but a power calculation was conducted that indica...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.